365 related articles for article (PubMed ID: 24624895)
1. The effect of adipose stem cell therapy on pulmonary fibrosis induced by repetitive intratracheal bleomycin in mice.
Lee SH; Lee EJ; Lee SY; Kim JH; Shim JJ; Shin C; In KH; Kang KH; Uhm CS; Kim HK; Yang KS; Park S; Kim HS; Kim YM; Yoo TJ
Exp Lung Res; 2014 Apr; 40(3):117-25. PubMed ID: 24624895
[TBL] [Abstract][Full Text] [Related]
2. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis.
Tashiro J; Elliot SJ; Gerth DJ; Xia X; Pereira-Simon S; Choi R; Catanuto P; Shahzeidi S; Toonkel RL; Shah RH; El Salem F; Glassberg MK
Transl Res; 2015 Dec; 166(6):554-67. PubMed ID: 26432923
[TBL] [Abstract][Full Text] [Related]
4. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice].
Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852
[TBL] [Abstract][Full Text] [Related]
5. [Human placental mesenchymal stem cells of fetal origin relieves mouse pulmonary fibrosis via downregulating MyD88 and TGF-β signaling pathway].
Tao J; Li Q; Ma X; Han F; Liu X; Wei J; Zhu Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Oct; 32(10):1347-1351. PubMed ID: 27667460
[TBL] [Abstract][Full Text] [Related]
6. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S
Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734
[TBL] [Abstract][Full Text] [Related]
7. Effect of IL-2-Bax, a novel interleukin-2-receptor-targeted chimeric protein, on bleomycin lung injury.
Segel MJ; Aqeilan R; Zilka K; Lorberboum-Galski H; Wallach-Dayan SB; Conner MW; Christensen TG; Breuer R
Int J Exp Pathol; 2005 Oct; 86(5):279-88. PubMed ID: 16191100
[TBL] [Abstract][Full Text] [Related]
8. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
[TBL] [Abstract][Full Text] [Related]
9. Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis.
Degryse AL; Tanjore H; Xu XC; Polosukhin VV; Jones BR; McMahon FB; Gleaves LA; Blackwell TS; Lawson WE
Am J Physiol Lung Cell Mol Physiol; 2010 Oct; 299(4):L442-52. PubMed ID: 20562227
[TBL] [Abstract][Full Text] [Related]
10. Bleomycin-induced pulmonary fibrosis is attenuated by an antibody against KL-6.
Xu L; Yang D; Zhu S; Gu J; Ding F; Bian W; Rong Z; Shen C
Exp Lung Res; 2013 Aug; 39(6):241-8. PubMed ID: 23672275
[TBL] [Abstract][Full Text] [Related]
11. The Fas/Fas-ligand system is not required for bleomycin-induced pulmonary fibrosis in mice.
Aoshiba K; Yasui S; Tamaoki J; Nagai A
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):695-700. PubMed ID: 10934108
[TBL] [Abstract][Full Text] [Related]
12. [The pivotal role of CXCR3 in the pathogenesis of bleomycin-induced pulmonary fibrosis].
Gao JM; Lu B
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jan; 28(1):28-32. PubMed ID: 15774188
[TBL] [Abstract][Full Text] [Related]
13. Effects of delayed treatment with transforming growth factor-beta soluble receptor in a three-dose bleomycin model of lung fibrosis in hamsters.
Wang Q; Hyde DM; Gotwals PJ; Giri SN
Exp Lung Res; 2002 Sep; 28(6):405-17. PubMed ID: 12217209
[TBL] [Abstract][Full Text] [Related]
14. Biphasic effects of free radical scavengers against bleomycin-induced pulmonary fibrosis.
Fujita M; Mizuta Y; Ikegame S; Ouchi H; Ye Q; Harada E; Inoshima I; Yoshimi M; Watanabe K; Nakanishi Y
Pulm Pharmacol Ther; 2008 Oct; 21(5):805-11. PubMed ID: 18655842
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
Corbel M; Caulet-Maugendre S; Germain N; Molet S; Lagente V; Boichot E
J Pathol; 2001 Apr; 193(4):538-45. PubMed ID: 11276015
[TBL] [Abstract][Full Text] [Related]
16. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.
Yasui H; Gabazza EC; Tamaki S; Kobayashi T; Hataji O; Yuda H; Shimizu S; Suzuki K; Adachi Y; Taguchi O
Am J Respir Crit Care Med; 2001 Jun; 163(7):1660-8. PubMed ID: 11401891
[TBL] [Abstract][Full Text] [Related]
17. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice.
Izumo T; Kondo M; Nagai A
Life Sci; 2007 Apr; 80(20):1882-6. PubMed ID: 17397875
[TBL] [Abstract][Full Text] [Related]
18. Effect of Intratracheal Administration of Adipose-derived Stromal Cells on Bleomycin-induced Lung Injury in a Rat Model.
Uji M; Nakada A; Nakamura T; Hirata K
Osaka City Med J; 2015 Dec; 61(2):81-91. PubMed ID: 26995852
[TBL] [Abstract][Full Text] [Related]
19. Ameliorative effect of mepenzolate bromide against pulmonary fibrosis.
Kurotsu S; Tanaka K; Niino T; Asano T; Sugizaki T; Azuma A; Suzuki H; Mizushima T
J Pharmacol Exp Ther; 2014 Jul; 350(1):79-88. PubMed ID: 24769542
[TBL] [Abstract][Full Text] [Related]
20. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
